Fraunhofer-Gesellschaft

Publica

Hier finden Sie wissenschaftliche Publikationen aus den Fraunhofer-Instituten.

Enhancement of T cell recruitment and infiltration into tumours

 
: Oelkrug, Christopher; Ramage, J.M.

:

Clinical and experimental immunology 178 (2014), Nr.1, S.1-8
ISSN: 0009-9104
ISSN: 0964-2536
Englisch
Zeitschriftenaufsatz
Fraunhofer IZI ()
cancer; T cells; tumour immunology

Abstract
Studies have documented that cancer patients with tumours which are highly infiltrated with cytotoxic T lymphocytes show enhanced survival rates. The ultimate goal of cancer immunotherapy is to elicit high-avidity tumour-specific T cells to migrate and kill malignant tumours. Novel antibody therapies such as ipilumimab (a cytotoxic T lymphocyte antigen-4 blocking antibody) show enhanced T cell infiltration into the tumour tissue and increased survival. More conventional therapies such as chemotherapy or anti-angiogenic therapy and recent therapies with oncolytic viruses have been shown to alter the tumour microenvironment and thereby lead to enhanced T cell infiltration. Understanding the mechanisms involved in the migration of high-avidity tumour-specific T cells into tumours will support and provide solutions for the optimization of therapeutic options in cancer immunotherapy.

: http://publica.fraunhofer.de/dokumente/N-322184.html